RISE: What is the reason for allowing “Annex A” OTCs to participate and what is the expected Impact? Is it for Europe to gain the OTC’s knowledge for Europe’s benefit, or to stimulate improvement in the OTC’s capacity for research and innovation? Or is it a combination of both?

The RISE action is set as:
a. The RISE scheme will promote international and inter-sector collaboration through research and innovation staff exchanges, and sharing of knowledge and ideas from research to market (and vice-versa) for the advancement of science and the development of innovation.
b. The scheme fosters a shared culture of research and innovation that welcomes and rewards creativity and entrepreneurship and helps to turn creative ideas into innovative products, services or processes. (2014-2015 Work Programme).